Virtual Press Room

The Virtual Press Room is a courtesy for corporate and institutional public relations professionals. Publication of material on this page does not constitute an endorsement by ASCO of any product or claim.

For information about how to submit a press release to the Virtual Press Room, visit the For PR Professionals page.

2014 ASCO Annual Meeting

Agendia
Multiple Studies on Agendia’s MammaPrint and BluePrint Tests to Be Featured at ASCO Annual Meeting

Boehringer Ingelheim
New data for Boehringer Ingelheim’s Gilotrif® (afatinib) shows a significant improvement in overall survival in lung cancer patients whose tumors have the most common EGFR mutation

Brown University
Getting chemo first may help in rectal cancer

Caris Life Sciences
Caris Life Sciences Advances Precision Medicine for Cancer Patients through Groundbreaking Tumor Profiling Research at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting

City of Hope
City of Hope researchers report on young adult cancer patients, location of cancer care, medication nonadherence and phase II drug trials of XL184 (cabozantinib) for breast cancer and ABT-888 (veliparib) for lung cancer

Dendreon
Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno-Oncology Data at the 2014 ASCO Annual Meeting

Fox Chase Cancer Center
Identification of Central Nervous Sysytem Involvement at Diagnosis Does Not Affect Overall Survival for Patients with AIDS-Related Lymphomas

Fox Chase Trial Uncovers Potential Dangers of Chemotherapy Regimen for Bladder Cancer Patients

Fox Chase Finds that Genetic Profile Predicts Which Bladder Cancer Patients Will Benefit From Early Chemotherapy

Fox Chase Research Find More Patients with Ovarian Cancer Are Recieving Chemotherapy Before Surgery

Hepatitis C Reactivation Does not Worsen Survival Outcomes for HIV + Patients Diagnosed with Lymphoma

Research Shows Overall Survival Benefit for Patients with Stage III Soft Tissue Sarcomas

Janssen
Janssen to Showcase Growing Body of Data at 2014 American Society of Clinical Oncology (ASCO) Annual Meeting

Memorial Sloan Kettering Cancer Center
Phase I Data Suggest PLX3397 Is a Potential Therapy for Patients with Advanced Pigmented Villonodular Synovitis

Myriad
Myriad Strengthens Commitment to Cancer Research at the ASCO 50th Annual Meeting

NRG Oncology
Patients with Head and Neck Cancer Who Have the KRAS-variant Genetic Mutation Live Longer When Treated with Cetuximab and Radiotherapy

OncoMed
OncoMed To Present Data from Three Clinical Studies at the 2014 ASCO Annual Meeting

Penn Medicine
Cancer Patient Demands Rarely Lead to Unnecessary Tests and Treatments

Large Panel Genetic Testing Produces More Questions than Answers in Breast Cancer

Pharmacyclics
Pharmacyclics Highlights Important New Data for IMBRUVICA® (ibrutinib) in B-Cell Malignancies

Pierre Fabre
Now hope for taxane resistant Advanced Breast Cancer patients (ABC) pretreated with or resistant to anthracyclines

Prima Biomed
CVAC DEMONSTRATES IMPROVEMENT IN PROGRESSION FREE SURVIVAL IN SECOND REMISSION OVARIAN CANCER

Provectus
PROVECTUS BIOPHARMACEUTICALS’ PV-10 DATA SHOW EXCEPTIONAL COMPLETE RESPONSE RATES IN REFRACTORY MELANOMA PATIENTS, STUDY EXAMINES COMPLETE RESPONSE AND INDUCED IMMUNE RESPONSE THAT MAY PRODUCE “BYSTANDER EFFECT” SEEN IN PATIENTS

Sequenta
Sequenta and Collaborators to Present Lymphoma and Immunotherapy Data at Annual Meeting of the American Society of Clinical Oncology

The Ohio State University Comprehensive Cancer Center
Genetic Basis of Lung Cancer Different for African Americans, Study Suggests

Study of ‘Super Responder’ Reveals New Oncogene for Lung Cancer

University Hospitals Case Medical Center
University Hospitals Case Medical Center Experts to Present Data at the 50th ASCO Annual Meeting Highlighting New Way to Predict Response to Chemotherapy
For Triple-Negative Breast Cancer Patients

University of Colorado Cancer Center
One Step Closer to a Breath Test for Lung Cancer

Tumor Responses with Crizotinib in MET-Amplified Disease Help Define a New Targetable Form of Lung Cancer